TÜSİAD Silicon Valley Network AI Webinar Series hosted it’s third event: “AI & Biotechnology”
TÜSİAD SVN hosted the third panel in the AI Webinar Series, “AI & Biotechnology”, on May 8, 2024.
Following opening remarks by TÜSİAD SVN Chair Ayşegül İldeniz, the panel was held through the moderation of Headland Strategy Group Consultant Bora Güner and the participation of our panelists: SiteAI Founder and CEO Özgü Tokgöz, Ernst & Young Health Industry Leader and Partner Arda Ural, Massive Bio Founder and CEO Selin Kurnaz and Genentech AI Researcher Gökçen Eraslan.
The panel discussed the effect of the rapid progress of AI technologies on biotechnology and health sectors. The panelists leveraged their different perspectives on these sectors to discuss how AI technologies affect investment trends, creative approaches in pre-clinical and clinical research, drug discovery and production processes and many other aspects of these fields.
Yoı can find the video of the event below: